| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2021 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.02B | 4.65B | 4.72B | 4.75B | 4.59B | 4.64B |
| Gross Profit | 138.30M | 1.81B | 2.02B | 2.24B | 2.12B | 1.80B |
| EBITDA | 854.90M | 849.80M | 656.20M | 896.70M | 863.60M | 398.90M |
| Net Income | 127.20M | 127.50M | -15.90M | 87.10M | 636.40M | -327.20M |
Balance Sheet | ||||||
| Total Assets | 3.36B | 3.66B | 3.81B | 4.41B | 3.83B | 8.44B |
| Cash, Cash Equivalents and Short-Term Investments | 421.00M | 171.40M | 496.50M | 791.40M | 787.70M | 968.90M |
| Total Debt | 1.27B | 1.35B | 1.60B | 2.99B | 1.41B | 4.28B |
| Total Liabilities | 2.72B | 2.95B | 3.17B | 3.66B | 2.95B | 7.27B |
| Stockholders Equity | 622.70M | 696.70M | 633.30M | 740.20M | 876.60M | 1.21B |
Cash Flow | ||||||
| Free Cash Flow | 432.00M | 597.80M | 324.00M | 402.30M | -184.80M | 628.80M |
| Operating Cash Flow | 643.80M | 754.20M | 543.30M | 580.20M | 66.80M | 959.80M |
| Investing Cash Flow | -214.70M | -150.90M | -10.20M | 73.00M | 2.08B | -306.10M |
| Financing Cash Flow | -470.80M | -641.50M | -776.30M | -640.90M | -2.89B | -481.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.32B | 16.25 | 16.69% | 1.27% | 1.69% | 276.44% | |
74 Outperform | £3.85B | 9.27 | 11.57% | 2.37% | 9.93% | 1.93% | |
64 Neutral | £1.02B | 8.29 | 19.28% | 3.66% | -6.21% | 0.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | £1.23B | 8.05 | 30.56% | ― | 10.71% | -101.29% | |
47 Neutral | £138.43M | -0.47 | 160.47% | ― | -19.76% | 61.69% | |
42 Neutral | £81.14M | -8.83 | -5.70% | 0.90% | 8.64% | -143.74% |